Clinical trials
Phase 1/2 Carcinoma, Hepatocellular trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Amgen | 1 |
| BioInvent International AB | 1 |
| Cellestia Biotech AG | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Johannes Gutenberg University Mainz | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 15 |
| Colorectal Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
| Endometrial Neoplasms | 1 |
| Glomus Tumor | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.